Short interest dropped 17.7% over the past week while borrowing costs remain elevated. Ryde Group reports Q1 results April 28 with limited analyst coverage and no recent institutional activity.
Short interest stands at 847,000 shares, or 1.23% of free float, as of April 23. The metric fell 11.8% overnight and 17.7% over the past week. One-month short interest is up 43.2%, suggesting recent position-building followed by profit-taking. Days to cover sits at 1.0 per FINRA's April 15 settlement data.
Borrowing costs are 37.7% APR, down 23.9% over the past week from a peak above 52% on April 13. Utilization is 79.8%, well below the 52-week high of 96.9%. The decline in both metrics suggests shorts are covering and fewer new positions are being established.
Coverage is minimal and stale. Maxim Group issued the last rating in May 2024, raising its target from $8 to $9 while maintaining a Buy rating. The firm's current $9 target is nearly 7x the $1.24 closing price. No other analysts cover the stock.
Enterprise value is $9.5 million as of October 2025. No current PE, P/B, or P/S multiples are available. Factor scores are unavailable across momentum, quality, and value. The ORTEX short score is 59.0, indicating moderate short pressure relative to the broader market.
No insider trades are recorded in the past 90 days. Top holders include Junming Zou with 8.2% (added 10.1 million shares in March) and Octava Offshore Holdings with 4.9%. Jane Street added 60,258 shares in Q4 2025. Recent institutional activity is light.
RYDE last reported on April 24, 2026, just yesterday. The stock fell 16.2% that day. Prior prints occurred October 2025 and April 2025. The stock is up 210% over the past month but down 16.8% over the past week, suggesting high volatility around events.
No active ORTEX Alpha signals.
See the live data behind this article on ORTEX.
Open RYDE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.